Pazopanib and HDAC inhibitors interact to kill sarcoma cells

Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells

(2013) Brunilde Gril et al.   AMERICAN JOURNAL OF PATHOLOGY

Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells

(2013) M Santoni et al.   BRITISH JOURNAL OF CANCER

First line treatment of metastatic renal cell carcinoma

(2013) Roberto Iacovelli et al.   CANCER BIOLOGY & THERAPY

Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy

(2013) Nichola Cruickshanks et al.   CANCER BIOLOGY & THERAPY

Pazopanib in sarcomas

(2013) Breelyn A. Wilky et al.   CURRENT OPINION IN ONCOLOGY

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer

(2013) Daniel Chan et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells

(2013) Sin-Gu Jeong et al.   NEUROSCIENCE LETTERS

Acetylation: A Novel Link between Double-Strand Break Repair and Autophagy

(2012) G. Shubassi et al.   CANCER RESEARCH

Novel targets for VEGF-independent anti-angiogenic drugs

(2012) Marco Petrillo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression

(2012) Dario Barbone et al.   PLoS One

Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells

(2011) M. D. Bareford et al.   CANCER RESEARCH

Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage

(2011) Daniel R. Premkumar et al.   MOLECULAR CARCINOGENESIS

Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells

(2010) Margaret A. Park et al.   MOLECULAR CANCER THERAPEUTICS

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

(2009) Kristy J. Gotink et al.   ANGIOGENESIS